Compare ARK Genomic Revolution ETF (ARKG) vs Nvidia Corp (NVDA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Nvidia Corp — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Nvidia Corp trades at $208.52 (market cap $5.11T). The key difference: Nvidia Corp pays a 0.47% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Nvidia Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | NVDA | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $235.75 |
52-Week Low | $23.09 | $164.07 |
Market Cap | — | $5.11T |
Enterprise Value | — | $5.04T |
Dividend Yield | — | 0.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NVIDIA (NVDA) trades at $210.96, up 4.07% in the last session, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.87 exceeding the $1.76 estimate. Revenue surged to $130.50 billion in 2025, driving a net income margin of 62.97%. Analyst consensus is strongly bullish, with a price target of $324.95.
The outlook remains positive due to NVIDIA's AI chip dominance and accelerating revenue growth, though risks include peak AI spending concerns and increased competition. The stock offers significant upside to the consensus target, but investors should weigh valuation multiples against execution risks in a dynamic market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →
